Showing results (171-180 of 181) with videos related to

Sort By:
Pageof 19
ESMO Open|April 5, 2021
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational studyF Schettini, B Conte, G Buono, et al.
The Journal of Clinical Endocrinology and Metabolism|December 12, 2001
Guidelines for diagnosis and therapy of MEN type 1 and type 2M L Brandi, R F Gagel, A Angeli, et al.
ESMO Open|August 9, 2024
Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trialF Poggio, E Blondeaux, M Tagliamento, et al.
ESMO Open|November 28, 2024
Identifying predictors of treatment response and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in hormone receptor-positive/HER2-negative breast cancer: the NEOENDO translational studyF Schettini, F Brasó-Maristany, T Pascual, et al.
ESMO Open|April 10, 2025
Prevalence and clinical impact of germline pathogenic variants in breast cancer: a descriptive large single-center studyA Rodriguez-Hernandez, O Martínez-Sáez, F Brasó-Maristany, et al.
ESMO Open|June 29, 2024
Unraveling the clinicopathological and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in hormone receptor-positive/HER2-low and HER2-0 breast cancerF Schettini, S Nucera, F Brasó-Maristany, et al.
ESMO Open|January 7, 2025
Linking tumor immune infiltration to enhanced longevity in recurrence-free breast cancerL Angelats, L Paré, C Rubio-Perez, et al.
ESMO Open|October 1, 2025
Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trialE Seguí, F Brasó-Maristany, T Pascual, et al.
American Journal of Human Genetics|July 31, 1998
Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disordersS Giraud, C X Zhang, O Serova-Sinilnikova, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 17, 2024
TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapyM Martín, S R Stecklein, O Gluz, et al.
Pageof 19